Fosun International’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,730
| Closed | -$483K | – | 46 |
|
|
2023
Q3 | $483K | Hold |
2,730
| – | – | 0.08% | 54 |
|
|
2023
Q2 | $519K | Hold |
2,730
| – | – | 0.07% | 50 |
|
|
2023
Q1 | $547K | Buy |
+2,730
| New | +$547K | 0.05% | 51 |
|
|
2019
Q3 | – | Sell |
-54,300
| Closed | -$3.86M | – | 232 |
|
|
2019
Q2 | $3.86M | Buy |
54,300
+6,000
| +12% | +$427K | 0.25% | 59 |
|
|
2019
Q1 | $4.38M | Hold |
48,300
| – | – | 0.28% | 50 |
|
|
2018
Q4 | $3.31M | Buy |
48,300
+11,800
| +32% | +$809K | 0.2% | 58 |
|
|
2018
Q3 | $3.29M | Buy |
+36,500
| New | +$3.29M | 0.16% | 64 |
|